These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 43514)

  • 21. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.
    Jusko WJ; Gardner MJ; Mangione A; Schentag JJ; Koup JR; Vance JW
    J Pharm Sci; 1979 Nov; 68(11):1358-66. PubMed ID: 41932
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes in apparent functions of component proteins of adenylate cyclase system in rat brain by drugs acting on the central nervous system.
    Ishibashi S; Kurokawa T; Dan'ura T; Yamashita A
    Adv Exp Med Biol; 1988; 236():287-99. PubMed ID: 2907239
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.
    Dixon CI; Rosahl TW; Stephens DN
    Pharmacol Biochem Behav; 2008 Jul; 90(1):1-8. PubMed ID: 18313124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid tolerance and crosstolerance to motor impairment effects of benzodiazepines, barbiturates, and ethanol.
    Khanna JM; Kalant H; Chau A; Shah G
    Pharmacol Biochem Behav; 1998 Feb; 59(2):511-9. PubMed ID: 9477002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anxiety; pharmacological bases of treatment].
    de Andrés Rodríguez-Trelles F
    An R Acad Nac Med (Madr); 1981; 98(1):69-116. PubMed ID: 6115590
    [No Abstract]   [Full Text] [Related]  

  • 26. Benzodiazepines: from receptor to function in sleep.
    Tallman JF
    Sleep; 1982; 5 Suppl 1():S12-7. PubMed ID: 6125021
    [No Abstract]   [Full Text] [Related]  

  • 27. Anxiolytic therapy. Oral and intravenous sedation.
    Henderson BN; Triplett RG; Gage TW
    Dent Clin North Am; 1994 Oct; 38(4):603-17. PubMed ID: 7805937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral pharmacology and toxicology.
    Bignami G
    Annu Rev Pharmacol Toxicol; 1976; 16():329-66. PubMed ID: 7185
    [No Abstract]   [Full Text] [Related]  

  • 29. Feeding and temperature changes in sheep following injections of barbiturates, Ca-++, or Mg-++ into the lateral, third, or fourth ventricle or cerebral aqueduct.
    Seoane JR; Baile CA
    J Dairy Sci; 1975 Apr; 58(4):515-20. PubMed ID: 1127157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food carrying in rats is blocked by the putative anxiolytic agent buspirone.
    Dringenberg HC; Kornelsen RA; Vanderwolf CH
    Pharmacol Biochem Behav; 1994 Nov; 49(3):741-6. PubMed ID: 7862731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperphagia induced by direct administration of midazolam into the parabrachial nucleus of the rat.
    Higgs S; Cooper SJ
    Eur J Pharmacol; 1996 Oct; 313(1-2):1-9. PubMed ID: 8905322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminable effects of benzodiazepines.
    Overton DA
    Psychopharmacol Commun; 1976; 2(4):339-43. PubMed ID: 11529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of galanthamine and galanthamine-eunalgit combination on food motor reflexes in cats.
    Navrátil J; Medek A; Hrbek J; Komenda S
    Act Nerv Super (Praha); 1979 Oct; 21(3):177-8. PubMed ID: 42268
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23-0364, in the rat.
    Yerbury RE; Cooper SJ
    Pharmacol Biochem Behav; 1989 Jun; 33(2):303-7. PubMed ID: 2573076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
    Heilig M; McLeod S; Brot M; Heinrichs SC; Menzaghi F; Koob GF; Britton KT
    Neuropsychopharmacology; 1993 Jun; 8(4):357-63. PubMed ID: 8099792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus.
    Gamber KM; Macarthur H; Westfall TC
    Neuropharmacology; 2005 Oct; 49(5):646-52. PubMed ID: 15949823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological studies on zopiclone.
    Julou L; Bardone MC; Blanchard JC; Garret C; Stutzmann JM
    Pharmacology; 1983; 27 Suppl 2():46-58. PubMed ID: 6142468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sedative-hypnotic drugs: interaction with calcium channels.
    Leslie SW
    Alcohol Drug Res; 1985-1986; 6(6):371-7. PubMed ID: 2425820
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats.
    Davidson AB; Weidley E
    Life Sci; 1976 Jun; 18(11):1279-84. PubMed ID: 6855
    [No Abstract]   [Full Text] [Related]  

  • 40. Benzodiazepine-induced hyperphagia in the nondeprived rat: comparisons with CL 218,872, zopiclone, tracazolate and phenobarbital.
    Cooper SJ; Moores WR
    Pharmacol Biochem Behav; 1985 Aug; 23(2):169-72. PubMed ID: 2865747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.